Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Asset Writedowns and Impairment (2019 - 2024)

Heron Therapeutics' Asset Writedowns and Impairment history spans 6 years, with the latest figure at $828000.0 for Q3 2024.

  • For Q3 2024, Asset Writedowns and Impairment rose 437.66% year-over-year to $828000.0; the TTM value through Sep 2024 reached $4.4 million, up 716.05%, while the annual FY2023 figure was $617000.0, 195.22% up from the prior year.
  • Asset Writedowns and Impairment reached $828000.0 in Q3 2024 per HRTX's latest filing, down from $3.3 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $3.3 million in Q2 2024 to a low of $8000.0 in Q3 2020.
  • Average Asset Writedowns and Impairment over 5 years is $337894.7, with a median of $124000.0 recorded in 2021.
  • Peak YoY movement for Asset Writedowns and Impairment: soared 2811.11% in 2020, then tumbled 84.22% in 2021.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $786000.0 in 2020, then crashed by 84.22% to $124000.0 in 2021, then crashed by 36.29% to $79000.0 in 2022, then skyrocketed by 94.94% to $154000.0 in 2023, then surged by 437.66% to $828000.0 in 2024.
  • Per Business Quant, the three most recent readings for HRTX's Asset Writedowns and Impairment are $828000.0 (Q3 2024), $3.3 million (Q2 2024), and $170000.0 (Q1 2024).